XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total Precipio, Inc. [Member]
Noncontrolling Interest in Joint Venture [Member]
Total
Balance at beginning of period at Dec. 31, 2019   $ 79,000 $ 74,065,000 $ (60,939,000) $ 13,205,000   $ 13,205,000
Balance at beginning of period (in shares) at Dec. 31, 2019 47 7,898,117          
Increase (Decrease) in Stockholders' Equity              
Net (loss) income       (8,756,000) (8,756,000) $ 27,000 $ (8,729,000)
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares)             2,060,000
Conversion of convertible notes into common stock   $ 39,000 2,137,000   2,176,000   $ 2,176,000
Conversion of convertible notes into common stock (in shares)   3,908,145          
Issuance of common stock in connection with purchase agreements   $ 49,000 6,872,000   6,921,000   6,921,000
Issuance of common stock in connection with purchase agreements (in shares)   4,870,654          
Proceeds upon issuance of common stock from exercise of stock options     3,000   3,000   3,000
Proceeds upon issuance of common stock from exercise of stock options (in shares)   1,229          
Write-off debt premiums (net of debt discounts) in conjunction with convertible note conversions     270,000   270,000   270,000
Write-off beneficial conversion feature in conjunction with convertible note extinguishment     (523,000)   (523,000)   (523,000)
Sock-based compensation     541,000   541,000   541,000
Balance at end of period at Sep. 30, 2020   $ 167,000 83,362,000 (69,695,000) 13,834,000 27,000 13,861,000
Balance at end of period (in shares) at Sep. 30, 2020 47 16,676,916          
Balance at beginning of period at Jun. 30, 2020   $ 146,000 78,857,000 (66,393,000) 12,610,000 17,000 12,627,000
Balance at beginning of period (in shares) at Jun. 30, 2020 47 14,616,916          
Increase (Decrease) in Stockholders' Equity              
Net (loss) income       (3,302,000) (3,302,000) 10,000 (3,292,000)
Issuance of common stock in connection with purchase agreements   $ 21,000 4,293,000   4,314,000   4,314,000
Issuance of common stock in connection with purchase agreements (in shares)   2,060,000          
Proceeds upon issuance of common stock from exercise of stock options     3,000   3,000   3,000
Proceeds upon issuance of common stock from exercise of stock options (in shares)   1,229          
Sock-based compensation     212,000   212,000   212,000
Balance at end of period at Sep. 30, 2020   $ 167,000 83,362,000 (69,695,000) 13,834,000 27,000 13,861,000
Balance at end of period (in shares) at Sep. 30, 2020 47 16,676,916          
Balance at beginning of period at Dec. 31, 2020   $ 176,000 85,523,000 (71,564,000) 14,135,000 27,000 14,162,000
Balance at beginning of period (in shares) at Dec. 31, 2020 47 17,576,916          
Increase (Decrease) in Stockholders' Equity              
Net (loss) income       (6,325,000) (6,325,000) 10,000 (6,315,000)
Issuance of common stock in connection with at the market offering, net of issuance costs   $ 45,000 14,902,000   14,947,000   14,947,000
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares)   4,501,000          
Issuance of common stock in connection with purchase agreements   $ 5,000 1,255,000   1,260,000   1,260,000
Issuance of common stock in connection with purchase agreements (in shares)   500,000          
Proceeds upon issuance of common stock from exercise of warrants   $ 1,000 399,000   400,000   400,000
Proceeds upon issuance of common stock from exercise of warrants (in shares)   74,000          
Proceeds upon issuance of common stock from exercise of stock options             3,000
Issuance of common stock for consulting services   $ 200,000 150,000   150,000   150,000
Issuance of common stock for consulting services (in shares)   55,147          
Sock-based compensation     1,310,000   1,310,000   1,310,000
Balance at end of period at Sep. 30, 2021   $ 227,000 103,542,000 (77,889,000) 25,880,000 37,000 25,917,000
Balance at end of period (in shares) at Sep. 30, 2021 47 22,708,292          
Balance at beginning of period at Jun. 30, 2021   $ 227,000 103,029,000 (76,029,000) 27,227,000 31,000 27,258,000
Balance at beginning of period (in shares) at Jun. 30, 2021 47 22,707,063          
Increase (Decrease) in Stockholders' Equity              
Net (loss) income       (1,860,000) (1,860,000) 6,000 (1,854,000)
Proceeds upon issuance of common stock from exercise of stock options             3,000
Issuance of common stock for consulting services   $ 0          
Issuance of common stock for consulting services (in shares)   0          
Sock-based compensation     510,000   510,000   510,000
Balance at end of period at Sep. 30, 2021   $ 227,000 $ 103,542,000 $ (77,889,000) $ 25,880,000 $ 37,000 $ 25,917,000
Balance at end of period (in shares) at Sep. 30, 2021 47 22,708,292